GABBR1 and pancreatic neoplasm: A recent study by Schuller et al. (2008) [36] demonstrated that GABBR1 could inhibit beta-adrenoreceptors (β-AR) signaling in pancreatic cancer cells, thus blocking the driving forces of cancer progression such as cell proliferation and cell migration; this indicates the unexpected involvement of GABBR1 in cancer genesis.